Synthesis of TML prodrug
Supplementary Figure 1 . Synthesis of the TML prodrug.
Compound 2 was synthesised as previously described 1 .
1-O-tert-Butyldimethylsilyl-3-(2′-hydroxy-4′,6′-dimethyl-5′-benzyloxyphenyl)-3,3-dimethylpropanol (3)
t-Butyldimethylsilyl chloride (9.75 g, 64.7 mmol) was added to a solution of 2 (16.9 g, 53.7 mmol) and DMAP (9.84 g, 80.5 mmol) in anhydrous THF (200 mL) at 0-5°C. The reaction was stirred for 20 h at room temperature. The mixture was then extracted with AcOEt (200 mL), washed with water (200 mL) and brine (100 mL × 3), and dried over anhydrous MgSO4. 
AcOH (160 mL) and water (160 mL) were added to a solution of 4 (28.4 g, 53.7 mmol) in THF (250 mL), and the solution was then stirred for 4 h at 40°C. The reaction mixture was diluted with AcOEt (200 mL); washed with water (200 mL), saturated aqueous solution of NaHCO3 (100 mL × 3), and brine (200 mL Preparation of TML prodrug EDC (2.00 g, 10.4 mmol) and DMAP (63.8 mg, 0.52 mmol) were added to a solution of brinzolamide (2.00 g, 5.22 mmol) and 7 (3.36 g, 7.83 mmol) in CH2Cl2 (45 mL) at 0-5°C, and the reaction mixture was stirred for 18 h at room temperature. The resultant mixture was diluted with CHCl3 (25 mL). The solution was washed with saturated aqueous solution of NaHCO3, saturated aqueous solution of NH4Cl, and water and dried over anhydrous MgSO4.
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The solution was concentrated under reduced pressure and purified with chromatography on silica gel with eluent AcOEt/MeOH (50:1) followed by removal of solvent in vacuo to afford 
